8-K Quince Therapeutics, Inc. 2026-09-04: filed_by
| Value | {"cik": "0001662774", "company": "Quince Therapeutics, Inc.", "accession": "0001193125-26-382838", "entity_ref": "22c5667b-8a9f-4fdf-aee8-0be4ac03b1c0", "period_of_report": "2026-08-31"} |
|---|---|
| Period | (as of 2026-09-04) |
| Status | current |
| Entity | 8-K Quince Therapeutics, Inc. 2026-09-04 |
Provenance
Source: SEC EDGAR 8-K — amtlicher Ereignisstrom (Current Reports) (Public Domain (17 U.S.C. §105))
Reference: https://www.sec.gov/Archives/edgar/data/1662774/000119312526382838/0001193125-26-382838-in
Retrieved: 2026-09-04T14:50:47.397590+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/62c25df2-75b8-427e-b831-2cc147e46c5c
Source: SEC EDGAR 8-K — amtlicher Ereignisstrom (Current Reports) (Public Domain (17 U.S.C. §105))
Reference: https://www.sec.gov/Archives/edgar/data/1662774/000119312526382838/0001193125-26-382838-in
Retrieved: 2026-09-04T14:50:47.397590+02:00
Raw response sha256:
7648cbf0882f6848fd0bc8f60fa3c475…Cite as: FACTANKER, https://factanker.com/fact/62c25df2-75b8-427e-b831-2cc147e46c5c
History
- no predecessors — first report